Hind Hafsi, Pierre Hainaut. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » Antineoplastic Agents/therapeutic useApoptosisCell Line, TumorHumansMelanoma/drug therapyProtein FoldingQuinuclidines/therapeutic useTumor Suppressor Protein p53/geneticsTumor Suppressor Protein p53/metabolism
Substances: See more » 2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-oneAntineoplastic AgentsQuinuclidinesTumor Suppressor Protein p53
Year: 2011 PMID: 21358263
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 4.534